Facial reconstruction

Search LJMU Research Online

Browse Repository | Browse E-Theses

Greater mechanistic understanding of the cutaneous pathogenesis of Stevens-Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review

Ogiji, ED, Aboheimed, N, Ross, K, Voller, C, Siner, R, Jensen, RL, Jolly, CE and Carr, DF (2024) Greater mechanistic understanding of the cutaneous pathogenesis of Stevens-Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review. Current Opinion in Allergy and Clinical Immunology, 24 (4). pp. 218-227. ISSN 1528-4050

[img]
Preview
Text
greater_mechanistic_understanding_of_the_cutaneous.7 (1).pdf - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Purpose of review Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) are severe cutaneous adverse drug reactions (SCARs) characterized by widespread epithelial detachment and blistering, which affects the skin and mucocutaneous membranes. To date, therapeutic interventions for SJS/TEN have focused on systematic suppression of the inflammatory response using high-dose corticosteroids or intravenous immunoglobulin G (IgG), for example. No targeted therapies for SJS/TEN currently exist. Recent findings Though our understanding of the pathogenesis of SJS/TEN has advanced from both an immunological and dermatological perspective, this knowledge is yet to translate into the development of new targeted therapies. Summary Greater mechanistic insight into SJS/TEN would potentially unlock new opportunities for identifying or repurposing targeted therapies to limit or even prevent epidermal injury and blistering.

Item Type: Article
Uncontrolled Keywords: drug hypersensitivity; drug repurposing; pathogenesis; Stevens-Johnson syndrome; toxic epidermal necrolysis; drug hypersensitivity; drug repurposing; pathogenesis; Stevens-Johnson syndrome; toxic epidermal necrolysis; Skin; Animals; Humans; Stevens-Johnson Syndrome; Adrenal Cortex Hormones; Immunoglobulins, Intravenous; Molecular Targeted Therapy; Stevens-Johnson Syndrome; Humans; Immunoglobulins, Intravenous; Skin; Adrenal Cortex Hormones; Animals; Molecular Targeted Therapy; 1107 Immunology; Allergy
Subjects: R Medicine > R Medicine (General)
R Medicine > RM Therapeutics. Pharmacology
R Medicine > RS Pharmacy and materia medica
Divisions: Pharmacy and Biomolecular Sciences
Publisher: Lippincott, Williams & Wilkins
SWORD Depositor: A Symplectic
Date Deposited: 08 Nov 2024 14:13
Last Modified: 08 Nov 2024 14:15
DOI or ID number: 10.1097/ACI.0000000000000993
URI: https://researchonline.ljmu.ac.uk/id/eprint/24719
View Item View Item